Status:
COMPLETED
Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy
Lead Sponsor:
Maisonneuve-Rosemont Hospital
Collaborating Sponsors:
Fonds de la Recherche en Santé du Québec
Fondation Antoine Turmel
Conditions:
Depression
Age-related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this trial is to determine the short-term effect of a self-care intervention on depression in patients with age-related macular degeneration or diabetic retinopathy.
Eligibility Criteria
Inclusion
- clinical diagnosis of wet or dry AMD or diabetic retinopathy
- age 50 years and older
- at least mild depressive symptoms (a score of 5 or more on the PHQ-9)
- no legal blindness (visual acuity better than 20/200 in better eye).
Exclusion
- the current use of cognitive behavioural therapy
- suicidal intent
- ocular surgery during the study period (intravitreal anti-VEGF injections will be allowed, e.g. Lucentis)
- cognitive impairment
- inability to speak and understand French or English
- profound hearing impairment.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02261194
Start Date
October 1 2014
End Date
February 1 2016
Last Update
November 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada, H1T2M4